Clinical Trials on Adjunct to Hemostasis in Vascular Surgery (Synthetic Vascular Grafts) in United Kingdom
Total 159 results
-
Baxter Healthcare CorporationCompletedAdjunct to Hemostasis in Vascular Surgery (Synthetic Vascular Grafts)United States
-
Baxter Healthcare CorporationCompletedHemostasis in Participants Receiving Peripheral Vascular Expanded Polytetrafluoroethylene (ePTFE) Graft ProsthesesUnited States
-
Edwards LifesciencesTerminatedModerate to High-risk Noncardiac SurgeryUnited States
-
Lombard MedicalWithdrawnAAA Graft Implant for Primary Aneurysm Treatment | AAA Graft Repair to Extend Life of ImplantUnited States
-
Unity Health TorontoApplied Health Research CentreRecruitingAtherosclerosis | Coronary Artery Bypass Graft Surgery | Vein OcclusionCanada, United States
-
University of EdinburghCSL Behring; NHS LothianCompletedCoagulopathy in Patients Having Thoraco-Abdominal Aneurysm RepairUnited Kingdom
-
Zimmer BiometActive, not recruitingArthritis, Rheumatoid | Avascular Necrosis | Arthritis, Degenerative | Revision Surgery | Conditions Consequent to Earlier Operations | Arthritis;TraumaticBelgium, United Kingdom, Switzerland, Germany
-
MedicureCompletedMyocardial Ischemia | Reperfusion Injury | Coronary Artery Bypass Graft SurgeryCanada, United States
-
University of VermontCompletedCoronary Artery Disease | Coronary Artery Bypass Graft SurgeryUnited States
-
Abbott Medical DevicesTerminatedAtrial Fibrillation | Coronary Arteriosclerosis | Coronary Artery Bypass Graft SurgeryCanada, United Kingdom, Netherlands, Norway, Finland, Germany
-
MedicureCompletedMyocardial Ischemia | Reperfusion Injury | Coronary Artery Bypass Graft Surgery | Myocardial RevascularizationCanada, United States
-
Novo Nordisk A/SCompletedAcquired Bleeding Disorder | Cardiac Surgery Requiring Cardiopulmonary BypassUnited States, Denmark, United Kingdom, Germany, Canada
-
Novo Nordisk A/SCompletedAcquired Bleeding Disorder | Bleeding During/Following SurgeryGermany, Sweden, United Kingdom, Spain, Canada, Australia, France
-
Novo Nordisk A/SCompletedAcquired Bleeding Disorder | Cardiac Surgery Requiring Cardiopulmonary BypassUnited States, Israel, Germany, Canada, Sweden, United Kingdom, Spain, Italy, Denmark, Japan
-
Autolus LimitedEnrolling by invitationMultiple Myeloma | DLBCL | T Cell Lymphoma | Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy | ALL, Adult and PediatricUnited Kingdom
-
Wake Forest University Health SciencesTerminatedSurgery | Regional Anesthesia Morbidity | Anticoagulants and Bleeding DisordersUnited States
-
Novo Nordisk A/SCompletedAcquired Bleeding Disorder | Bleeding During/Following SurgeryIsrael, Sweden, United Kingdom, Germany, Switzerland, France, Spain, Italy, Thailand, Denmark, United States, Poland, Finland, Singapore, Australia, Austria
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI); University of Texas Southwestern... and other collaboratorsRecruitingMyocardial Infarction | Heart Failure | Atrial Fibrillation | Genetic Predisposition to Disease | Heart; Dysfunction Postoperative, Cardiac SurgeryUnited States
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia B | Relatives to/Carers of PatientsSpain, Canada, United Kingdom
-
Novo Nordisk A/STerminatedAcquired Bleeding Disorder | Cardiac Surgery Requiring Cardiopulmonary BypassUnited States, Spain, Germany, Sweden, United Kingdom, Argentina, Italy, Brazil, Denmark, France, India, Malaysia, Singapore, South Africa
-
Novo Nordisk A/STerminatedAcquired Bleeding Disorder | Bleeding During/Following SurgeryUnited States
-
National Cancer Institute (NCI)CompletedMultiple Myeloma | Graft vs Host DiseaseUnited States
-
University of Colorado, DenverNational Cancer Institute (NCI); Karyopharm Therapeutics IncRecruitingMultiple Myeloma in RelapseUnited States
-
University of PittsburghNovartisWithdrawnMultiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbNo longer availableMultiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Fred Hutchinson Cancer CenterCompletedLymphoma | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Graft Versus Host DiseaseUnited States
-
Travera IncMassachusetts General Hospital; Dana-Farber Cancer Institute; Weill Medical College... and other collaboratorsRecruitingMultiple Myeloma in RelapseUnited States
-
Washington University School of MedicineBristol-Myers Squibb; CelgeneActive, not recruitingMultiple Myeloma in RelapseUnited States, Canada
-
Washington University School of MedicineCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Multiple Myeloma | Leukemia, Myelogenous, ChronicUnited States
-
Roswell Park Cancer InstituteActive, not recruitingHodgkin Lymphoma | Waldenstrom Macroglobulinemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Plasma Cell Myeloma | Myeloproliferative Neoplasm | Minimal Residual Disease | Graft Versus Host Disease | Severe Aplastic Anemia | Acute Myeloid Leukemia in Remission | Adult Acute Lymphoblastic Leukemia... and other conditionsUnited States
-
Luminary TherapeuticsThe Cleveland Clinic; Case Western Reserve UniversityRecruitingMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
Ajai ChariCelgene CorporationCompletedMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
Gadeta B.V.Active, not recruitingMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
Dana-Farber Cancer InstituteNational Institutes of Health (NIH); Genus Oncology, LLCWithdrawnMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
University of Illinois at ChicagoCompletedMultiple Myeloma, Relapsed | Multiple Myeloma, Refractory to Standard TreatmentUnited States
-
University of IowaCompletedThe Focus of the Study is to Monitor MRI Signal Changes and Inflammatory Biomarkers With Use of Aspirin in Patients With Unruptured Cerebral AneurysmUnited States
-
National Cancer Institute (NCI)CompletedMultiple Myeloma | Chronic Lymphocytic Leukemia | Graft vs Host Disease | Non Hodgkin's Lymphoma | Hodgkin's DiseaseUnited States
-
CelgeneCelgene CorporationCompletedMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States, Australia
-
Alliance Foundation Trials, LLC.Pharmacyclics LLC.Active, not recruitingMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Cogent Biosciences, Inc.Seagen Inc.TerminatedMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
National Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Graft Versus Host DiseaseUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.; Celgene CorporationActive, not recruitingMultiple Myeloma in RelapseUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnPlasma Cell Myeloma | Plasma Cell Leukemia in RemissionUnited States
-
Omar Nadeem, MDTakedaRecruitingMultiple Myeloma | Multiple Myeloma in RelapseUnited States
-
All4CureGlaxoSmithKlineRecruitingMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma, RefractoryUnited States
-
Scripps Translational Science InstituteCue HealthActive, not recruitingImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised IndividualsHIV Infections | Lymphoma | Leukemia | Cancer | Multiple Myeloma | Immunosuppression | Immunodeficiency | Transplant | Graft Versus Host Disease | Age-Related ImmunodeficiencyUnited States
-
New Mexico Cancer Care AllianceNovartisTerminatedMultiple Myeloma in RelapseUnited States
-
Fortis Therapeutics, Inc.CompletedMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma With Failed RemissionUnited States
-
AmgenCompletedBone Metastases in Men With Hormone-Refractory Prostate Cancer | Bone Metastases in Subjects With Advanced Breast Cancer | Bone Metastases in Subjects With Advanced Cancer or Multiple MyelomaUnited Kingdom, Czech Republic